Lithium_bromide.pmd

LITHIUM BROMIDE
H.M.S. Beagle
180 English Landing Drive
Suites 110-120
Parkville, MO 64152
816-587-9998
www.hms-beagle.com
1. Product Identification
Synonyms: Lithium Monobromide
CAS No.: 7550-35-8
Molecular Weight: 86.845
Chemical Formula: LiBr
Product Codes: CHEM-630 and others.
2. Composition/Information on Ingredients
3. Hazards Identification
EMERGENCY OVERVIEW
May cause central nervous system effects. May cause cardiac disturbances. May cause kidney
damage. Warning! Causes digestive and respiratory tract irritation. May be harmful if
swallowed. Causes eye and skin irritation and possible burns
.
Target Organs: Blood, kidneys, central nervous system, cardiovascular system.
SAF-T-DATA(tm) Ratings
Health Rating: 2 - Moderate
Flammability Rating: 0 - None
Reactivity Rating: 0 - None
Contact Rating: 1 - Slight
Lab Protective Equip: GOGGLES; LAB COAT; VENT HOOD; PROPER GLOVES
Storage Color Code: Green (General Storage)
Potential Health Effects
Eye:
Causes eye irritation and possible burns.
Skin:
Chronic ingestion may cause dizziness, ringing in the ears, visual disturbances, tremors, and
mental confusion. Exposure to bromides may cause rashes, especially of the face (resembling acne)
and boils. Anhydrous lithium bromide is extremely hygroscopic and contact with tissue can
produce a dehydrating action resulting in localized burns.
Ingestion:
May cause central nervous system depression. May cause disturbed blood electrolyte balance.
Causes gastrointestinal tract irritation. Large doses of lithium may cause dizziness, prostration,
and kidney damage. Dehydration, weight loss, slurred speech, blurred vision, sensory loss, ataxia,
tremors, and convulsions may occur. May be harmful if swallowed. May produce depression,
emaciation with severe cases resulting in pyschosis and mental deterioration.
Inhalation:
May cause severe irritation of the upper respiratory tract with pain, burns, and inflammation.
Chronic:
Chronic ingestion may cause dizziness, ringing in the ears, visual disturbances, tremors, and
mental confusion. Prolonged absorption may affect electrolyte balance and impair kidney
function. Dehydration, weight loss, skin effects, and thyroid disturbances have been reported.
Chronic exposure may cause kidney damage.
4. First Aid Measures
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper
and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of soap and water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Do NOT induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never
give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure to fresh air immediately. If breathing is
difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
5. Fire Fighting Measures
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH
(approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This material in sufficient quantity
and reduced particle size is capable of creating a dust explosion.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire. Cool containers with flooding
quantities of water until well after fire is out. Use water spray, dry chemical, carbon dioxide, or
appropriate foam.
Flash Point:
Not applicable.
Autoignition Temperature:
Not applicable.
Explosion Limits, Lower:
Not available.
Upper:
Not available.
NFPA Rating:
(estimated) Health: 2; Flammability: 0; Instability: 0
6. Accidental Release Measures
General Information:
Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills
immediately, observing precautions in the Protective Equipment section. Avoid generating dusty
conditions. Provide ventilation.
7. Handling and Storage
Handling:
Wash thoroughly after handling. Wash hands before eating. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust generation and
accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing.
Keep container tightly closed. Do not ingest or inhale.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from
incompatible substances. Store protected from moisture.
8. Exposure Controls/Personal Protection
Engineering Controls: Facilities storing or utilizing this material should be equipped with an
eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations
low.
Exposure Limits
Chemical Name

OSHA - Final PELs
OSHA Vacated PELs: Lithium bromide: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA’s eye
and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA’s 29 CFR 1910.134 and ANSI Z88.2
requirements or European Standard EN 149 must be followed whenever workplace conditions
warrant a respirator’s use.
9. Physical and Chemical Properties
Physical State:
Powder
Appearance:
white
Odor:
none reported
pH:
Neutral/Alkaline
Vapor Pressure:
1.0 mm Hg @ 748°C
Vapor Density:
Not available.
Evaporation Rate:
Not applicable.
Viscosity:
Not applicable.
Boiling Point:
1265°C
Freezing/Melting Point:
547°C
Decomposition Temperature:
Not available.
Solubility:
Soluble.
Specific Gravity/Density:
3.464 @ 35°C
10. Stability and Reactivity
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, moisture, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture, strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen bromide, oxides of lithium.
Hazardous Polymerization:
Will not occur.
11. Toxicological Information
RTECS#:
CAS#
7550-35-8: OJ5755000
LD /LC :
CAS# 7550-35-8:Oral, mouse: LD = 1840 mg/kg; Carcinogenicity:
CAS# 7550-35-8: Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Epidemiology:
No information available.
Teratogenicity:
No information available.
Reproductive Effects:
No information available.
Neurotoxicity:
No information available.
Mutagenicity:
No information available.
Other Studies:
No information available.
12. Ecological Information
Environmental Fate:
No information found.
Environmental Toxicity:
No information found.
13. Disposal Considerations
Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts
261.3. Additionally, waste generators must consult state and local hazardous waste regulations to
ensure complete and accurate classification.
RCRA P-Series:
None listed.
RCRA U-Series:
None listed.
14. Transport Information
15. Regulatory Information
US FEDERAL
TSCA
CAS# 7550-35-8 is listed on the TSCA inventory.
Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA.
SARA
CERCLA Hazardous Substances and corresponding RQs
None of the chemicals in this material have an RQ.
SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ.
SARA Codes
CAS # 7550-35-8: flammable.
Section 313
No chemicals are reportable under Section 313.
Clean Air Act:
This material does not contain any hazardous air pollutants. This material does not contain any
Class 1 Ozone depletors. This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
None of the chemicals in this product are listed as Hazardous Substances under the CWA. None of
the chemicals in this product are listed as Priority Pollutants under the CWA. None of the
chemicals in this product are listed as Toxic Pollutants under the CWA.
OSHA:
None of the chemicals in this product are considered highly hazardous by OSHA.
STATE
CAS# 7550-35-8 is not present on state lists from CA, PA, MN, MA, FL, or NJ.
California No Significant Risk Level: None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7550-35-8: 1
Canada - DSL/NDSL
CAS# 7550-35-8 is listed on Canada’s DSL List.
Canada - WHMIS
This product has a WHMIS classification of D2B.
16. Other Information
Product Use:
Laboratory Reagent; Consumer Hobby.
Revision Information:
None
Disclaimer:
************************************************************************************************
H.M.S. Beagle and/or Rainbow House, LLC, provides the information contained herein in good
faith but makes no representation as to its comprehensiveness or accuracy. This document is
intended only as a guide to the appropriate precautionary handling of the material by a
properly trained person using this product. Individuals receiving the information must exercise
their independent judgment in determining its appropriateness for a particular purpose.
NEITHER H.M.S. BEAGLE NOR RAINBOW HOUSE, LLC MAKE NO REPRESENTATIONS
OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION
ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE
WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT TO
WHICH THE INFORMATION REFERS. ACCORDINGLY, H.M.S. BEAGLE AND RAINBOW
HOUSE, LLC, WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF
OR RELIANCE UPON THIS INFORMATION.
************************************************************************************************
Prepared by: John Farrell Kuhns
Phone Number: 816-587-9998 (U.S.A.)

Source: http://billbutterworth.safe-orders.net/MSDS/Lithium_Bromide.pdf

ukrin.com

INT. J. IMMUNOTHERAPY XIX(2-4) 129-134 (2003)PROTECTIVE EFFECT OF UKRAIN AGAINST ACUTE ACETAMINOPHEN-LEVINA O.A.,1 GONCHAROVA I.A.,2 FILATOVA T.G.,1 NADEEV A.P.,3 NOWICKY W.,4SUKHENKO T.G.,5 KOLESNIKOVA O.P.,5 KOROLENKO T.A.11) Laboratory of Cellular Biochemistry, Institute of Physiology, Russian Academy of Medical Sciences,2) First Hospital of Municipal Infectious Diseases, Novosibirsk, Russ

Albert m. kligman, m.d., ph.d

Curriculum Vitae Albert M. Kligman, M.D., Ph.D Professor Emeritus of Dermatology University of Pennsylvania School of Medicine Clinical Research Building 226 Clinical Research Building 415 Curie Boulevard Philadelphia, PA 19104-6142 U.S.A. Education 1942-47 M.D. University of Pennsylvania School of Medicine Postgraduate Training and Fellowship Appointments Interned,

Copyright © 2018 Medical Abstracts